Michael LaBarre
Chief Tech/Sci/R&D Officer bij HALOZYME THERAPEUTICS, INC.
Vermogen: 7 M $ op 31-03-2024
Actieve functies van Michael LaBarre
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2020 | - |
| General Counsel | - | 01-01-2020 | |
| Corporate Officer/Principal | 16-06-2008 | 24-08-2015 |
Loopbaan van Michael LaBarre
Eerdere bekende functies van Michael LaBarre
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01-12-2003 | 01-04-2006 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | 01-11-1995 | 01-12-2003 |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Corporate Officer/Principal | - | - |
Opleiding van Michael LaBarre
| Stony Brook University | Undergraduate Degree |
| University of Arizona | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
- Beurs
- Insiders
- Michael LaBarre
- Ervaring
